Keeping the Sentinels of the Brain Vigilant

Ivana Magovčević-Liebisch, president and CEO of Vigil Neuroscience, discusses the role of microglia, what happens to these immune cells in the rare, neurodegenerative condition ALSP; and why the company’s therapeutic approach can have implications for a range of rare and common neurodegenerative conditions.